Patched 2 Antikörper (AA 226-235)
-
- Target Alle Patched 2 (PTCH2) Antikörper anzeigen
- Patched 2 (PTCH2)
-
Bindungsspezifität
- AA 226-235
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Patched 2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Maus
- Aufreinigung
- Affinity chromatography purified
- Immunogen
- PTCH2 antibody was raised in rabbit using AA 226-235 [GPFASLEGFR] of the human PTCH2 protein as the immunogen.
- Isotyp
- IgG
- Top Product
- Discover our top product PTCH2 Primärantikörper
-
-
- Applikationshinweise
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- Lot specific
- Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
- Target
- Patched 2 (PTCH2)
- Andere Bezeichnung
- PTCH2 (PTCH2 Produkte)
- Hintergrund
- Mutations of the human Patched tumor suppressor gene (PTCH) have been identified in individuals with the nevoid basal cell carcinoma syndrome (NBCCS) as well as in sporadic basal cell carcinomas and medulloblastomas. PTCH2 has a frameshift mutation resulting in a truncated PTCH2 protein.
- Pathways
- Hedgehog Signalweg
-